RxDoctor Payments Data

Jason Bartos, MD

Interventional Cardiology · Minneapolis, MNNPI 1366755878

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,699 of the $6,972 with a category attached, or 67.4%. 18 manufacturers reported payments, led by Getinge USA Sales, LLC at 42.3% of the total. Reporting peaked in 2022 at $2,237 and has fallen 73.0% since, to $604 in 2025. That places this record below the midpoint for interventional cardiology clinicians in MN, where the typical reported total is $5,396.

$6,972in general payments, 2019–2025

Across 84 payments — averaging $83.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Getinge USA Sales, LLC$3K
  • Stryker$637
  • Boston Scientific$595
  • Angiodynamics, Inc.$490
  • Abbott$406
  • Medtronic$338
  • plus $2K from 12 others

What the payments were for

  • Consulting fees$1,60023%
  • Travel & lodging$67310%
  • Food & beverage$4,69967%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,972 in reported general payments places this provider in the 50th percentile of 84 interventional cardiology providers in Minnesota.

See all interventional cardiology providers in Minnesota

Medicare billing

Part B allowed, 2024
$88,108
Medicare patients
140
Services billed
604

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor22$15,510
Atorvastatin Calcium51$717
Metoprolol Succinate36$627
Carvedilol24$570
ClopidogrelClopidogrel Bisulfate35$547
Losartan Potassium22$325
Rosuvastatin Calcium25$232
Lisinopril27$201
Amlodipine Besylate20$185

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →